Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Parkinson's Disease

  Free Subscription


05.01.2026

3 Ann Neurol
1 Biol Psychiatry
2 BMC Neurol
2 Brain Res
4 J Neural Transm (Vienna)
1 J Neurochem
1 J Neurol Neurosurg Psychiatry
3 Mov Disord
1 Nat Rev Neurol
4 Neurobiol Dis
1 Neurochem Res
1 Neurologia (Engl Ed)
1 Neurology
2 Neuroscience
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. PIAT C, Mullan AF, Ghoniem K, Turcano P, et al
    Autonomic Dysfunction and Risk of Mortality in Early-Onset Parkinson's Disease.
    Ann Neurol. 2025 Dec 31. doi: 10.1002/ana.78143.
    PubMed         Abstract available

  2. SIMEK M, Tykalova T, Novotny M, Illner V, et al
    Speech Biomarkers From Smartphone Calls Track Progression in REM Sleep Behavior Disorder and Parkinson's Disease.
    Ann Neurol. 2025 Dec 30. doi: 10.1002/ana.78140.
    PubMed         Abstract available

  3. TALWAR P, Mortazavi N, Koshmanova E, Muto V, et al
    Age-Related Differences in the Association between REM Sleep and the Polygenic Risk for Parkinson's Disease.
    Ann Neurol. 2025 Dec 25. doi: 10.1002/ana.78112.
    PubMed         Abstract available


    Biol Psychiatry

  4. BARBIER M, Peterschmitt Y, Bereau M, Risold PY, et al
    Is the Medial Subthalamic Region in Humans Homologous to That in Rodents? Relevance to Neuropsychiatric Disorders and Their Treatment With Deep Brain Stimulation.
    Biol Psychiatry. 2026;99:200-209.
    PubMed         Abstract available


    BMC Neurol

  5. SUN Y, Li S, Shi S, Liu Y, et al
    Association between inflammatory markers and Parkinson's disease risk: a cross-sectional, propensity score-matched analysis of NHANES data.
    BMC Neurol. 2025 Dec 27. doi: 10.1186/s12883-025-04598.
    PubMed         Abstract available

  6. WANG Y, Liu Y, Fang B, Liu C, et al
    Integrative analysis of mRNA and LncRNA profiles from small extracellular vesicles identifies apoptosis-related biomarkers in patients with Parkinson's disease after rehabilitation.
    BMC Neurol. 2025 Dec 28. doi: 10.1186/s12883-025-04594.
    PubMed        


    Brain Res

  7. WEN Z, He YZ, Hu ZX, Huang X, et al
    Molecular and neurochemical underpinnings of altered intrinsic neural timescales in Parkinson's disease: a multimodal imaging and transcriptomics study.
    Brain Res. 2025;1873:150133.
    PubMed         Abstract available

  8. GAO J, Qin K, Xian W, Ren J, et al
    LRRN3 protects dopaminergic neurons by inhibiting glycolysis in Parkinson's disease.
    Brain Res. 2025 Dec 19:150119. doi: 10.1016/j.brainres.2025.150119.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  9. BECHET S, Leonard M, Ademola E, Fritz JV, et al
    Precision prevention for neurodegenerative diseases: lessons learnt from Alzheimer's disease translated into perspectives for Parkinson's disease.
    J Neural Transm (Vienna). 2025 Dec 26. doi: 10.1007/s00702-025-03090.
    PubMed         Abstract available

  10. BARBOSA PM, Parmera JB, Warner TT
    Neuropathology in genetic Parkinson's disease: a focused review of pathological and clinical findings.
    J Neural Transm (Vienna). 2025 Dec 22. doi: 10.1007/s00702-025-03088.
    PubMed         Abstract available

  11. SANTOS-GARCIA D, de Deus Fonticoba T, Bartolome CC, Iniguez Alvarado MC, et al
    Influence of the level of education on cognitive function in Parkinson's disease.
    J Neural Transm (Vienna). 2025 Dec 22. doi: 10.1007/s00702-025-03074.
    PubMed         Abstract available

  12. JOST WH
    Dichotomous thinking in Parkinson therapy?
    J Neural Transm (Vienna). 2025 Dec 22. doi: 10.1007/s00702-025-03089.
    PubMed        


    J Neurochem

  13. KWON HJ, Jung HY, Yoo DY, Moon SM, et al
    Neuroprotective Effects of PEP-1-PGAM5 via the Attenuation of Oxidative Stress and Apoptosis in Parkinson's Disease.
    J Neurochem. 2025;169:e70324.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  14. PENG X, Flores-Torres MH, Cortese M, Peng C, et al
    Epigenetic ageing and the risk of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2025 Dec 30:jnnp-2025-336802.
    PubMed         Abstract available


    Mov Disord

  15. LIU Y, Xiao B, Huang P, Li Y, et al
    Integration of Volumetric, Iron, and Neuromelanin Magnetic Resonance Imaging Measures Effectively Differentiates Parkinson's Disease from Multiple System Atrophy.
    Mov Disord. 2025 Dec 30. doi: 10.1002/mds.70153.
    PubMed         Abstract available

  16. HENDERSON MJ, Chen TC, Glasstetter LM, Chen Y, et al
    The Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies for GBA1-Associated Parkinsonism.
    Mov Disord. 2025 Dec 29. doi: 10.1002/mds.70168.
    PubMed         Abstract available

  17. GANOZA CA, Westenberger A, Paul JJ, Curado F, et al
    Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.
    Mov Disord. 2025 Dec 24. doi: 10.1002/mds.70161.
    PubMed         Abstract available


    Nat Rev Neurol

  18. RIZIG M, Salama M
    Genetic insights from Parkinson disease in African and African admixed populations.
    Nat Rev Neurol. 2026 Jan 2. doi: 10.1038/s41582-025-01177.
    PubMed        


    Neurobiol Dis

  19. BALLOTTO L, Baratta T, Winterberg H, Dusanter C, et al
    Nuclear ASC speck formation in microglia is associated with inflammasome priming and is exacerbated in LRRK2-G2019S Parkinson's disease.
    Neurobiol Dis. 2025 Dec 25:107237. doi: 10.1016/j.nbd.2025.107237.
    PubMed         Abstract available

  20. WANG M, Li Y, Yao J, Zhao W, et al
    Memory-guided saccade latency as a potential biomarker for axial symptoms and freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Dec 22:107238. doi: 10.1016/j.nbd.2025.107238.
    PubMed         Abstract available

  21. REZA A, Yanagisawa T, Tani N, Fukuma R, et al
    Wirelessly transmitted subthalamic nucleus signals decode endogenous pain levels in Parkinson's disease patients.
    Neurobiol Dis. 2025 Dec 22:107235. doi: 10.1016/j.nbd.2025.107235.
    PubMed         Abstract available

  22. RUAN X, Huang X, Wang M, Zhou Q, et al
    Network-wide morphometric organization deficits and transcriptomic correlates in Parkinson's disease with freezing of gait: A morphometric inverse divergence study.
    Neurobiol Dis. 2025 Dec 18:107230. doi: 10.1016/j.nbd.2025.107230.
    PubMed         Abstract available


    Neurochem Res

  23. DONG G, Fan L, Li C, Jiao Y, et al
    Schisanhenol Inhibits MPTP/MPP(+)-Induced Ferroptosis in Dopaminergic Neurons Via Nrf2/TrxR1/GPX4 Pathway against Parkinson's Disease.
    Neurochem Res. 2025;51:26.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  24. BENITO-LEON J, Benito-Rodriguez CM
    Comments on the article "Mortality rates for Parkinson's disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020.".
    Neurologia (Engl Ed). 2025 Dec 24:101893. doi: 10.1016/j.nrleng.2025.101893.
    PubMed        


    Neurology

  25. TSUKITA K, Kikuya A, Yoshimura K, Nakanishi E, et al
    Temporal Dynamics and Cross-Sectional and Longitudinal Factors Associated With Motor Reserve and Outcome in Patients With Parkinson Disease.
    Neurology. 2026;106:e214475.
    PubMed         Abstract available


    Neuroscience

  26. ZHAO L, Han K, Sun L
    Investigations on the effects of SH2B2 on Parkinson's disease based on its in vivo and in vitro neurotoxic model.
    Neuroscience. 2025 Dec 31:S0306-4522(25)01236.
    PubMed         Abstract available

  27. LI Y, Bo S, Qu JF, Ruan X, et al
    Alterations of functional connectivity between hyperdirect pathway regions and outside regions in Parkinson's disease patients with freezing of gait.
    Neuroscience. 2025 Dec 23:S0306-4522(25)01225.
    PubMed         Abstract available


    PLoS One

  28. WUNNENBERG E, Baumann N
    Group singing through the lens of polyvagal theory: A pilot study in patients with Parkinson's disease.
    PLoS One. 2025;20:e0337210.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.